0001062993-11-002388.txt : 20110526 0001062993-11-002388.hdr.sgml : 20110526 20110526192113 ACCESSION NUMBER: 0001062993-11-002388 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110524 FILED AS OF DATE: 20110526 DATE AS OF CHANGE: 20110526 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Geller Matthew CENTRAL INDEX KEY: 0001446201 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 11875767 MAIL ADDRESS: STREET 1: 248 CENTRAL PARK WEST CITY: NEW YORK STATE: NY ZIP: 10024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0303 4 2011-05-24 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001446201 Geller Matthew 248 CENTRAL PARK WEST NEW YORK NY 10024 1 0 0 0 Common Stock 2011-05-24 4 S 0 7700 24.0831 D 10000 D This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $24.00 to $24.10. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Matthew Geller by Carl A. Valenstein, attorney in fact 2011-05-26